{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:39:26Z","timestamp":1787499566182,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Toxicol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11419-022-00618-w","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T10:04:07Z","timestamp":1647252247000},"page":"403-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of serum and whole blood concentrations in quetiapine overdose cases"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4517-2060","authenticated-orcid":false,"given":"Takeshi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoatsu","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Namera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"618_CR1","volume-title":"Disposition of toxic drugs and chemicals in man","author":"RC Baselt","year":"2017","unstructured":"Baselt RC (2017) Disposition of toxic drugs and chemicals in man, 11th edn. Biomedical Publications, Seal Beach, CA","edition":"11"},{"key":"618_CR2","volume-title":"Clarke's Isolation and Identification of Drugs","author":"AC Moffatt","year":"1989","unstructured":"Moffatt AC (1989) Clarke\u2019s Isolation and Identification of Drugs, 2nd edn. Pharmaceutical Press, London","edition":"2"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.forsciint.2012.05.028","volume":"222","author":"E Saar","year":"2012","unstructured":"Saar E, Beyer J, Gerostamoulos D, Drummer OH (2012) The time-dependant post-mortem redistribution of antipsychotic drugs. Forensic Sci Int 222:223\u2013227","journal-title":"Forensic Sci Int"},{"key":"618_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dta.1507","volume":"6","author":"T Launiainen","year":"2014","unstructured":"Launiainen T, Ojanper\u00e4 I (2014) Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal 6:308\u2013316. https:\/\/doi.org\/10.1002\/dta.1507","journal-title":"Drug Test Anal"},{"key":"618_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/bdd.711","volume":"31","author":"T Uchimura","year":"2010","unstructured":"Uchimura T, Kato M, Saito T, Kinoshita H (2010) Prediction of human blood-to-plasma drug concentration ratio. Biopharm Drug Dispos 31:286\u2013297. https:\/\/doi.org\/10.1002\/bdd.711","journal-title":"Biopharm Drug Dispos"},{"key":"618_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.12740\/PP\/65307","volume":"51","author":"AE Urban","year":"2017","unstructured":"Urban AE, Cuba\u0142a WJ (2017) Therapeutic drug monitoring of atypical antipsychotics. Psychiatr Pol 51:1059\u20131077. https:\/\/doi.org\/10.12740\/PP\/65307","journal-title":"Psychiatr Pol"},{"key":"618_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/cap.2007.0084","volume":"18","author":"HR Winter","year":"2008","unstructured":"Winter HR, Earley WR, Hamer-Maansson JE, Davis PC, Smith MA (2008) Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders. J Child Adolescent Psychopharmacol 18:81\u201398. https:\/\/doi.org\/10.1089\/cap.2007.0084","journal-title":"J Child Adolescent Psychopharmacol"},{"key":"618_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/acps.12794","volume":"136","author":"I Castberg","year":"2017","unstructured":"Castberg I, Westin AA, Skogvoll E, Spigset O (2017) Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine. Acta Psychiatr Scand 136:455\u2013464. https:\/\/doi.org\/10.1111\/acps.12794","journal-title":"Acta Psychiatr Scand"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","volume":"40","author":"CL Devane","year":"2001","unstructured":"Devane CL, Nemeroff CB (2001) Clinical pharmacokinetics of quetiapine: An atypical antipsychotic. Clin Pharmacokine 40:509\u2013522. https:\/\/doi.org\/10.2165\/00003088-200140070-00003","journal-title":"Clin Pharmacokine"},{"key":"618_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2125.2005.02507.x","volume":"61","author":"SW Grimm","year":"2006","unstructured":"Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB (2006) Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol 61:58\u201369. https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02507.x","journal-title":"Br J Clin Pharmacol"},{"key":"618_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12024-018-0049-9","volume":"15","author":"RL Hughes","year":"2019","unstructured":"Hughes RL (2019) Fatal combination of mitragynine and quetiapine \u2013 a case report with discussion of a potential herb-drug interaction. Forensic Sci Med Path 15:110\u2013113. https:\/\/doi.org\/10.1007\/s12024-018-0049-9","journal-title":"Forensic Sci Med Path"},{"key":"618_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.7556\/jaoa.2012.112.12.792","volume":"112","author":"W Prozialeck","year":"2012","unstructured":"Prozialeck W, Jivan J, Andurkar S (2012) Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects. J Am Osteopath Assoc 112:792\u2013799. https:\/\/doi.org\/10.7556\/jaoa.2012.112.12.792","journal-title":"J Am Osteopath Assoc"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/jat\/28.6.520","volume":"28","author":"LJ Langman","year":"2004","unstructured":"Langman LJ, Kaliciak HA, Carlyle S (2004) Fatal overdoses associated with quetiapine. J Anal Toxicol 28:520\u2013525. https:\/\/doi.org\/10.1093\/jat\/28.6.520","journal-title":"J Anal Toxicol"},{"key":"618_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/jat\/bkv072","volume":"39","author":"L Skov","year":"2015","unstructured":"Skov L, Johansen SS, Linnet K (2015) Postmortem quetiapine reference concentrations in brain and blood. J Anal Toxicol 39:557\u2013561. https:\/\/doi.org\/10.1093\/jat\/bkv072","journal-title":"J Anal Toxicol"},{"key":"618_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","volume":"192","author":"TS Tracy","year":"2005","unstructured":"Tracy TS, Venkataramanan R, Glover DD, Caritis SN (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol 192:633\u2013639. https:\/\/doi.org\/10.1016\/j.ajog.2004.08.030","journal-title":"Am J Obstet Gynecol"}],"container-title":["Forensic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-022-00618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11419-022-00618-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-022-00618-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:08:12Z","timestamp":1655816892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11419-022-00618-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s11419-022-00618-w","relation":{},"ISSN":["1860-8965","1860-8973"],"issn-type":[{"value":"1860-8965","type":"print"},{"value":"1860-8973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest associated with this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Tokai University School of Medicine, and informed consent was obtained from all patients prior to study participation (17R 028).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}